Restricted accessResearch articleFirst published online 2002-7
Thrombocytopenia Caused by a Protein Pump Inhibitor;Hepatic Failure Associated with the Benzodiazepine Triazolam;Three Cases of Transient Encephalopathy with Paclitaxel;Thalidomide Problems: Hypothyroidism and Venous Thrombosis;Hypertensive Crisis with St. John's Wort
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
ShusterJ.ISMP adverse drug reactions.Hosp Pharm.2002; 37: 466.
ZiskeC.G., SchöttkerB., GorschlüterAcute transient encephalopathy after paclitaxel infusion: Report of three cases.Ann Oncol.2002; 13: 629–31.
5.
BadrosA.Z., SiegelE., BodennerD.Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.Am J Med.2002; 112: 412–13.
6.
EscudierB., LassauN., LeborgneS.Thalidomide and venous thrombosis [letter].Ann Int Med.2002; 136: 711.
7.
Hypericum Depression Trial Study Group.Effect of Hypericum perforatum (St. John's wort) in major depressive disorder—a randomized controlled trial.JAMA.2002; 287: 1807–14.
8.
PatelS., RobinsonR., BurkM.Hypertensive crisis associated with St. John's wort [letter].Am J Med.2002; 112: 507–8.
